More like 60M because the PDD trial is pivotal! This will precipitate and early look at the P3 AD trial which will show amplified results well beyond those of P2a because of switch to Mild ALZ only in P3 AD. So probably only 4 Million ALZ patients are going to be forced to die this year! About a million can be saved! By this move alone. And some reduction in dilution!
News 
Market Data 
Discover 
